Medfina - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 38,143 | 42,219 | 44,308 | 44,583 | 44,747 | 44,936 | 104,596 | 220,298 |
| Profit before tax | 13,861 | 15,398 | 16,341 | 23,088 | 33,275 | 15,925 | 60,379 | 143,361 |
| Net profit | 13,168 | 14,627 | 15,524 | 21,934 | 31,611 | 15,129 | 57,358 | 120,423 |
| Equity | 59,361 | 73,988 | 89,512 | 111,446 | 143,057 | 158,186 | 215,544 | 335,967 |
| Liabilities | 2,074 | 771 | 1,969 | 1,154 | 1,764 | 796 | 1,216,937 | 2,493,931 |
| Non-current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current assets | 61,289 | 74,759 | 91,481 | 112,600 | 144,778 | 158,982 | 1,432,481 | 2,829,898 |
| Total assets | 61,289 | 74,759 | 91,481 | 112,600 | 144,778 | 158,982 | 1,432,481 | 2,829,898 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 7,227 | 19,107 | 58,891 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +0.4% | +10.7% | +4.9% | +0.6% | +0.4% | +0.4% | +132.8% | +110.6% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 21.5% | 19.6% | 17.0% | 19.5% | 21.8% | 9.5% | 4.0% | 4.3% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 22.2% | 19.8% | 17.3% | 19.7% | 22.1% | 9.6% | 26.6% | 35.8% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 34.5% | 34.6% | 35.0% | 49.2% | 70.6% | 33.7% | 54.8% | 54.7% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 36.3% | 36.5% | 36.9% | 51.8% | 74.4% | 35.4% | 57.7% | 65.1% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 5.6 | 7.4 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 38,143 | 42,219 | 44,308 | 33,438 | 24,408 | 44,936 | 104,596 | 220,298 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Medfina - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2026-07-23 | 2026-08-02 | 2.15 |
| 2026-05-19 | 2026-05-25 | 664.90 |
| 2026-05-17 | 2026-05-17 | 2.05 |
| 2026-05-03 | 2026-05-14 | 2.05 |
| 2026-04-24 | 2026-04-29 | 2.05 |
| 2026-02-18 | 2026-02-25 | 879.16 |
| 2026-01-21 | 2026-02-17 | 1.56 |
| 2025-10-24 | 2025-11-02 | 1.67 |
| 2025-10-23 | 2025-10-23 | 666.45 |
| 2025-10-16 | 2025-10-22 | 664.78 |
| 2025-07-16 | 2025-07-24 | 619.27 |
| 2025-06-08 | 2025-06-09 | 1.06 |
| 2025-05-16 | 2025-06-04 | 1.06 |
| 2025-05-04 | 2025-05-12 | 1.06 |
| 2025-04-24 | 2025-04-29 | 1.06 |
| 2025-01-16 | 2025-01-22 | 488.57 |
Medfina - VMI tax arrears
As of 2026-09-14, the amount of overdue STI tax debt of the company Medfina is: 2 €
| From | To | Overdue, € |
|---|---|---|
| 2026-09-01 | 2026-09-14 | 1.96 |
| 2026-08-28 | 2026-08-31 | 2.47 |
| 2026-08-05 | 2026-08-09 | 3830.52 |
| 2026-08-02 | 2026-08-04 | 3832.91 |
| 2026-05-15 | 2026-05-18 | 625.2 |
| 2026-02-21 | 2026-02-27 | 2.72 |
| 2026-02-13 | 2026-02-20 | 624.08 |
| 2025-12-17 | 2025-12-17 | 3.04 |
| 2025-12-15 | 2025-12-16 | 623.92 |
| 2025-08-19 | 2025-08-25 | 2.88 |
| 2025-08-15 | 2025-08-18 | 642.83 |
| 2025-08-01 | 2025-08-14 | 14.83 |
| 2025-07-29 | 2025-07-31 | 11.71 |
| 2025-07-28 | 2025-07-28 | 3849.11 |
| 2025-07-16 | 2025-07-27 | 12.11 |
| 2025-07-01 | 2025-07-15 | 3084.74 |
| 2025-06-28 | 2025-06-30 | 3080.59 |
| 2025-05-01 | 2025-05-01 | 303.76 |
| 2025-04-30 | 2025-04-30 | 303.36 |
| 2025-04-28 | 2025-04-29 | 303.37 |
| 2025-04-16 | 2025-04-16 | 465.29 |
| 2025-03-29 | 2025-04-15 | 1.21 |
| 2025-03-27 | 2025-03-28 | 5.12 |
| 2025-03-15 | 2025-03-24 | 459.0 |
| 2024-12-30 | 2024-12-31 | 1.8 |
| 2024-12-18 | 2024-12-27 | 1.8 |
| 2024-12-17 | 2024-12-17 | 442.55 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Medfina, UAB (code 303359869) is a Private Limited Liability Company engaged in accounting, bookkeeping and auditing activities; tax consultancy. In 2025, the company generated revenue of €220.3K, up 110.6% year on year and 390.2% over two years. Net profit reached €120.4K, compared with €57.4K in 2024 and €15.1K in 2023, showing a clear upward trajectory in profitability. The 2025 profit margin was 54.7%, broadly in line with 2024 and above the 33.7% recorded in 2023. Balance sheet size also expanded, with total assets of €2.83M, equity of €336.0K and liabilities of €2.49M at the end of 2025. The equity ratio was 11.9%, while debt-to-equity stood at 7.42, indicating a leverage-heavy structure. Return on equity was 35.8% and return on assets 4.3%. Asset turnover remained low at 0.08x. Revenue and profit per employee were both €220.3K and €120.4K respectively for 2025.